RPS6KB1 and cancer: Hence, inhibition of PDK1, which is constitutively active and is capable of activating a number of AGC kinases (including Akt, S6K, SGK, PKC, PKN, and others), might ensure additional repression of cancer-relevant Akt-independent pathways in cancer cells [1].